TFC Financial Management
DNA icon

TFC Financial Management’s Ginkgo Bioworks DNA Stock Holding History

TFC Financial Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.85K Hold
300
– – ﹤0.01% 513
2026
Q2 		$2.97K Hold
300
– – ﹤0.01% 527
2026
Q1 		$1.84K Hold
300
– – ﹤0.01% 543
2025
Q4 		$2.49K Buy
+300
New +$3.23K ﹤0.01% 514
2022
Q4 		– Sell
-88
Closed -$11K – 541
2022
Q3 		$11K Buy
+88
New +$10.5K ﹤0.01% 306

Other funds holding DNA

J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Q Fund Management (Hong Kong)
Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return
Modera Wealth Management
Modera Wealth Management Westwood, New Jersey $9.5B AUM 16% 1-Year Est. Return
Boston Standard Wealth Management
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
TriaGen Wealth Management
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TFC Financial Management's DNA Position: Q3 2026 in Review

TFC Financial Management held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 300 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

TFC Financial Management first reported a position in DNA in Q3 2022 and has held it in 5 quarters since. The position peaked at $11K in Q3 2022. 29 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • TFC Financial Management held 300 shares of Ginkgo Bioworks worth $3.85K as of Q3 2026.
  • TFC Financial Management left its Ginkgo Bioworks share count unchanged in Q3 2026.
  • Ginkgo Bioworks made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #513 holding.
  • TFC Financial Management first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 5 quarters since.
  • TFC Financial Management's Ginkgo Bioworks position peaked at $11K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.